BUTENAFINE HYDROCHLORIDE

BUTENAFINE HYDROCHLORIDE was reported 595 times

BUTENAFINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STRANGULATED INCISIONAL HERNIA 1 0.2000
1 INFLAMMATION OF LACRIMAL PASSAGE 1 0.0200
2 T-LYMPHOCYTE COUNT ABNORMAL 1 0.0122
3 PHARYNGEAL STENOSIS 1 0.0097
4 TINEA CRURIS 4 0.0080
5 AUTOMATIC BLADDER 1 0.0072
6 SCROTAL ERYTHEMA 1 0.0060
7 ABDOMINAL STRANGULATED HERNIA 1 0.0055
8 GENITAL TRACT INFLAMMATION 1 0.0050
9 ROCKY MOUNTAIN SPOTTED FEVER 1 0.0047
10 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
11 NAIL PIGMENTATION 1 0.0041
12 EAR INFECTION BACTERIAL 1 0.0037
13 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
14 RESPIRATORY FUME INHALATION DISORDER 1 0.0032
15 MASKED FACIES 1 0.0025
16 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0022
17 PELVIC INFECTION 1 0.0022
18 ECZEMA ASTEATOTIC 1 0.0021
19 HERPES ZOSTER OTICUS 1 0.0020
20 TINEA INFECTION 2 0.0018
21 BODY TINEA 1 0.0018
22 NAIL INJURY 1 0.0018
23 FLASHBACK 1 0.0017
24 URETHRAL PAIN 1 0.0017
25 DIAPHRAGMATIC PARALYSIS 1 0.0017
26 ATYPICAL FRACTURE 1 0.0016
27 INFLAMMATORY PAIN 1 0.0015
28 GENITAL SWELLING 1 0.0014
29 PRODUCT LOT NUMBER ISSUE 3 0.0014
30 SERRATIA INFECTION 1 0.0013
31 SINUSITIS FUNGAL 1 0.0012
32 CHEMICAL INJURY 1 0.0012
33 GENITAL INFECTION FUNGAL 1 0.0012
34 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
35 GENITAL BURNING SENSATION 1 0.0012
36 APPLICATION SITE DISCOMFORT 2 0.0011
37 APPLICATION SITE DERMATITIS 1 0.0011
38 SPONTANEOUS HAEMORRHAGE 1 0.0010
39 BURNS THIRD DEGREE 1 0.0009
40 BONE DEMINERALISATION 1 0.0009
41 PRODUCT SELECTION ERROR 1 0.0009
42 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
43 BLOOD FIBRINOGEN DECREASED 1 0.0009
44 DRUG ADMINISTERED AT INAPPROPRIATE SITE 9 0.0009
45 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 2 0.0008
46 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15 0.0008
47 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
48 APPLICATION SITE WARMTH 1 0.0008
49 APPLICATION SITE PARAESTHESIA 1 0.0008
50 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
51 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
52 NAIL INFECTION 1 0.0007
53 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
54 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
55 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
56 TINEA PEDIS 1 0.0006
57 INCORRECT DOSAGE ADMINISTERED 3 0.0006
58 EXPIRED DRUG ADMINISTERED 3 0.0006
59 BLOOD AMYLASE INCREASED 1 0.0006
60 KYPHOSIS 1 0.0006
61 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
62 PRODUCT PRESCRIBING ISSUE 12 0.0006
63 JAUNDICE NEONATAL 1 0.0005
64 GINGIVAL DISORDER 2 0.0005
65 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
66 APPLICATION SITE PAIN 11 0.0005
67 EAR SWELLING 1 0.0005
68 NAIL DISORDER 4 0.0005
69 LIMB MASS 1 0.0005
70 READING DISORDER 1 0.0004
71 PRURITUS GENITAL 1 0.0004
72 SKIN ABRASION 2 0.0004
73 URINARY HESITATION 1 0.0004
74 STARING 1 0.0004
75 EXFOLIATIVE RASH 1 0.0004
76 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
77 THERAPEUTIC RESPONSE DELAYED 1 0.0004
78 ANAL HAEMORRHAGE 1 0.0004
79 DRUG EFFECT DECREASED 19 0.0004
80 PRODUCT LABEL CONFUSION 2 0.0003
81 LUMBAR SPINAL STENOSIS 1 0.0003
82 PROSTATITIS 1 0.0003
83 DRUG EFFECT INCREASED 1 0.0003
84 BLADDER PAIN 1 0.0003
85 SKIN EROSION 1 0.0003
86 APPLICATION SITE VESICLES 2 0.0003
87 BREAST ENLARGEMENT 1 0.0003
88 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
89 PRODUCT LABEL ISSUE 2 0.0003
90 APPLICATION SITE DRYNESS 1 0.0003
91 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
92 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
93 THERMAL BURN 2 0.0003
94 FIBRIN D DIMER INCREASED 1 0.0003
95 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
96 BLOOD PHOSPHORUS DECREASED 1 0.0003
97 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
98 SKIN IRRITATION 12 0.0003
99 DRUG PRESCRIBING ERROR 5 0.0003
100 NAIL DISCOLOURATION 1 0.0003
101 SKIN ODOUR ABNORMAL 1 0.0003
102 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
103 ARTERIOSPASM CORONARY 1 0.0002
104 VITAMIN B12 DEFICIENCY 1 0.0002
105 APPLICATION SITE DISCOLOURATION 1 0.0002
106 EXPIRED PRODUCT ADMINISTERED 8 0.0002
107 PRODUCT USE ISSUE 44 0.0002
108 APPLICATION SITE ERYTHEMA 6 0.0002
109 BLOOD CREATINE INCREASED 1 0.0002
110 RASH PAPULAR 5 0.0002
111 SUSPECTED OFF LABEL USE 1 0.0002
112 TUMOUR MARKER INCREASED 1 0.0002
113 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
114 APPLICATION SITE BURN 1 0.0002
115 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
116 APPLICATION SITE SWELLING 1 0.0002
117 FULL BLOOD COUNT DECREASED 4 0.0002
118 DYSPHORIA 1 0.0002
119 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
120 ANAL FISTULA 1 0.0002
121 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
122 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
123 BLOOD URIC ACID INCREASED 1 0.0002
124 BURNING SENSATION 12 0.0002
125 HEPATITIS B 1 0.0002
126 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
127 PHARYNGITIS 2 0.0002
128 APPLICATION SITE IRRITATION 2 0.0002
129 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
130 POOR QUALITY DRUG ADMINISTERED 1 0.0002
131 WRONG PRODUCT ADMINISTERED 1 0.0001
132 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
133 LARGE INTESTINE PERFORATION 1 0.0001
134 ORAL DISCOMFORT 2 0.0001
135 DRUG INEFFECTIVE 189 0.0001
136 APPLICATION SITE REACTION 1 0.0001
137 SKIN REACTION 2 0.0001
138 PAPULE 1 0.0001
139 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
140 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
141 APPLICATION SITE PRURITUS 3 0.0001
142 ACIDOSIS 1 0.0001
143 MUSCLE TWITCHING 3 0.0001
144 RENAL FAILURE CHRONIC 1 0.0001
145 AFFECTIVE DISORDER 1 0.0001
146 DRUG SCREEN POSITIVE 1 0.0001
147 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
148 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
149 RASH ERYTHEMATOUS 6 0.0001
150 BLISTER 7 0.0001
151 POST PROCEDURAL INFECTION 1 0.0001
152 SKIN DISORDER 4 0.0001
153 INADEQUATE ANALGESIA 1 0.0001
154 URINE OUTPUT DECREASED 1 0.0001
155 GROIN PAIN 1 0.0001
156 LYMPHOCYTE COUNT DECREASED 2 0.0001
157 PURPURA 1 0.0001
158 SKIN DISCOLOURATION 5 0.0001
159 THINKING ABNORMAL 2 0.0001
160 SQUAMOUS CELL CARCINOMA 1 0.0001
161 PRODUCT PACKAGING ISSUE 1 0.0001
162 KNEE OPERATION 1 0.0001
163 PRODUCT PHYSICAL ISSUE 2 0.0001
164 VAGINAL DISCHARGE 1 0.0001
165 EXTRA DOSE ADMINISTERED 4 0.0001
166 HELICOBACTER INFECTION 1 0.0001
167 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
168 POLLAKIURIA 4 0.0001
169 PRODUCT ODOUR ABNORMAL 1 0.0001
170 CONDITION AGGRAVATED 29 0.0001
171 INCONTINENCE 1 0.0001
172 RENAL PAIN 1 0.0001
173 RETCHING 2 0.0001
174 BREAST PAIN 1 0.0001
175 DISTURBANCE IN ATTENTION 5 0.0001
176 DECREASED ACTIVITY 1 0.0001
177 UNEVALUABLE EVENT 7 0.0001
178 PRURITUS GENERALISED 2 0.0001
179 ERYTHEMA 19 0.0001
180 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
181 FUNGAL INFECTION 3 0.0001
182 TOOTH DISORDER 2 0.0001
183 ORAL PAIN 2 0.0001
184 OCULAR DISCOMFORT 1 0.0001
185 REBOUND EFFECT 1 0.0001
186 MICTURITION URGENCY 1 0.0001
187 ELECTROLYTE IMBALANCE 1 0.0001
188 POST PROCEDURAL HAEMORRHAGE 1 0.0001
189 PRURITUS 33 0.0001
190 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
191 SKIN EXFOLIATION 7 0.0001
192 DRUG EFFECT INCOMPLETE 3 0.0001
193 CEREBRAL INFARCTION 2 0.0001
194 SPINAL OPERATION 1 0.0001
195 SARS-COV-2 TEST POSITIVE 1 0.0001
196 ADVERSE REACTION 1 0.0001
197 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
198 QUALITY OF LIFE DECREASED 1 0.0001
199 PERIPHERAL COLDNESS 1 0.0001
200 APPLICATION SITE RASH 1 0.0001
201 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
202 CARPAL TUNNEL SYNDROME 1 0.0001
203 RED BLOOD CELL COUNT DECREASED 2 0.0001
204 SKIN BURNING SENSATION 5 0.0001
205 PARAESTHESIA ORAL 1 0.0001
206 GASTROENTERITIS 1 0.0001
207 OFF LABEL USE 59 0.0001
208 COLON CANCER 1 0.0001
209 HYPOAESTHESIA ORAL 1 0.0001
210 ECONOMIC PROBLEM 1 0.0001
211 PHARYNGEAL OEDEMA 1 0.0001
212 BASAL CELL CARCINOMA 1 0.0001
213 PRODUCT USE COMPLAINT 1 0.0001
214 COAGULOPATHY 1 0.0001
215 CANDIDA INFECTION 1 0.0001
216 HAEMATURIA 2 0.0001
217 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
218 PARANOIA 1 0.0001
219 LOCAL SWELLING 1 0.0001
220 RASH PRURITIC 3 0.0001
221 LEUKOCYTOSIS 1 0.0001
222 PELVIC PAIN 1 0.0001
223 HEPATIC FUNCTION ABNORMAL 2 0.0001
224 MIDDLE INSOMNIA 1 0.0001
225 RASH 23 0.0001
226 BLOOD URINE PRESENT 1 0.0001
227 DRY SKIN 7 0.0001
228 SEROTONIN SYNDROME 1 0.0001
229 HAEMORRHOIDS 1 0.0001
230 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
231 SINUS DISORDER 1 0.0001
232 UPPER LIMB FRACTURE 1 0.0001
233 SPINAL FRACTURE 1 0.0000
234 TASTE DISORDER 1 0.0000
235 DISCOMFORT 3 0.0000
236 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
237 EATING DISORDER 1 0.0000
238 BLOOD CREATININE INCREASED 3 0.0000
239 FEBRILE NEUTROPENIA 3 0.0000
240 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
241 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
242 PRODUCT PRESCRIBING ERROR 1 0.0000
243 FIBROMYALGIA 1 0.0000
244 ABASIA 1 0.0000
245 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
246 ACNE 3 0.0000
247 PRODUCT COMPLAINT 1 0.0000
248 PERIPHERAL SWELLING 6 0.0000
249 ERECTILE DYSFUNCTION 1 0.0000
250 DRUG RESISTANCE 1 0.0000
251 INFLAMMATION 2 0.0000
252 SKIN ULCER 1 0.0000
253 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
254 PARAESTHESIA 6 0.0000
255 ANHEDONIA 1 0.0000
256 GASTRITIS 1 0.0000
257 HYPERSENSITIVITY 7 0.0000
258 EAR INFECTION 1 0.0000
259 JAUNDICE 1 0.0000
260 PAIN OF SKIN 1 0.0000
261 RESPIRATORY ARREST 1 0.0000
262 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
263 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
264 IRRITABILITY 2 0.0000
265 BLOOD POTASSIUM DECREASED 1 0.0000
266 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
267 MOOD SWINGS 1 0.0000
268 CHOLELITHIASIS 1 0.0000
269 DYSPEPSIA 3 0.0000
270 BLOOD PRESSURE DECREASED 2 0.0000
271 URINARY RETENTION 1 0.0000
272 EYE PRURITUS 1 0.0000
273 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
274 ANGER 1 0.0000
275 PRODUCT QUALITY ISSUE 4 0.0000
276 RASH MACULAR 1 0.0000
277 LYMPHADENOPATHY 1 0.0000
278 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
279 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
280 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
281 CRYING 1 0.0000
282 C-REACTIVE PROTEIN INCREASED 1 0.0000
283 DYSPNOEA EXERTIONAL 1 0.0000
284 HOT FLUSH 2 0.0000
285 ABNORMAL BEHAVIOUR 1 0.0000
286 DRY MOUTH 2 0.0000
287 PSORIATIC ARTHROPATHY 1 0.0000
288 NEUTROPHIL COUNT DECREASED 1 0.0000
289 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
290 ROAD TRAFFIC ACCIDENT 1 0.0000
291 SEPTIC SHOCK 1 0.0000
292 MENTAL DISORDER 1 0.0000
293 INTENTIONAL PRODUCT MISUSE 2 0.0000
294 INSOMNIA 6 0.0000
295 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
296 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
297 THROAT IRRITATION 1 0.0000
298 THERAPY NON-RESPONDER 1 0.0000
299 HYPOKALAEMIA 1 0.0000
300 COGNITIVE DISORDER 1 0.0000
301 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
302 PAIN IN EXTREMITY 6 0.0000
303 HYPOAESTHESIA 3 0.0000
304 FLUSHING 2 0.0000
305 PAIN 12 0.0000
306 SINUSITIS 2 0.0000
307 NERVOUSNESS 1 0.0000
308 PLATELET COUNT DECREASED 2 0.0000
309 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
310 TREATMENT NONCOMPLIANCE 1 0.0000
311 DEPENDENCE 1 0.0000
312 MEDICATION ERROR 1 0.0000
313 URTICARIA 3 0.0000
314 ABDOMINAL DISCOMFORT 3 0.0000
315 EYE PAIN 1 0.0000
316 MYALGIA 3 0.0000
317 DEPRESSION 4 0.0000
318 ANXIETY 5 0.0000
319 INCORRECT DOSE ADMINISTERED 4 0.0000
320 HERPES ZOSTER 1 0.0000
321 BACK PAIN 4 0.0000
322 SUICIDE ATTEMPT 1 0.0000
323 PLEURAL EFFUSION 1 0.0000
324 HYPERHIDROSIS 2 0.0000
325 AMNESIA 1 0.0000
326 SWELLING FACE 1 0.0000
327 ABDOMINAL PAIN UPPER 3 0.0000
328 WEIGHT DECREASED 4 0.0000
329 SLEEP DISORDER 1 0.0000
330 MOBILITY DECREASED 1 0.0000
331 INFECTION 2 0.0000
332 BRONCHITIS 1 0.0000
333 CHRONIC KIDNEY DISEASE 1 0.0000
334 BLOOD PRESSURE INCREASED 2 0.0000
335 DECREASED APPETITE 3 0.0000
336 ARTHRITIS 1 0.0000
337 CARDIAC FAILURE 1 0.0000
338 CONFUSIONAL STATE 2 0.0000
339 INFLUENZA LIKE ILLNESS 1 0.0000
340 CARDIAC ARREST 1 0.0000
341 TREMOR 2 0.0000
342 DIZZINESS 6 0.0000
343 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
344 MUSCULOSKELETAL STIFFNESS 1 0.0000
345 DRUG WITHDRAWAL SYNDROME 1 0.0000
346 SUICIDAL IDEATION 1 0.0000
347 ADVERSE EVENT 1 0.0000
348 NASOPHARYNGITIS 2 0.0000
349 DIARRHOEA 7 0.0000
350 OROPHARYNGEAL PAIN 1 0.0000
351 CHEST PAIN 2 0.0000
352 SWELLING 1 0.0000
353 ANAEMIA 2 0.0000
354 MIGRAINE 1 0.0000
355 GAIT DISTURBANCE 2 0.0000
356 ATRIAL FIBRILLATION 1 0.0000
357 NAUSEA 8 0.0000
358 SYNCOPE 1 0.0000
359 CHEST DISCOMFORT 1 0.0000
360 ILLNESS 1 0.0000
361 ABDOMINAL DISTENSION 1 0.0000
362 HAEMORRHAGE 1 0.0000
363 CONSTIPATION 2 0.0000
364 THROMBOCYTOPENIA 1 0.0000
365 MUSCULAR WEAKNESS 1 0.0000
366 PYREXIA 3 0.0000
367 PALPITATIONS 1 0.0000
368 CHILLS 1 0.0000
369 FEELING ABNORMAL 2 0.0000
370 EMOTIONAL DISTRESS 1 0.0000
371 VISUAL IMPAIRMENT 1 0.0000
372 ASTHENIA 3 0.0000
373 FATIGUE 6 0.0000
374 RENAL FAILURE 1 0.0000
375 NEUTROPENIA 1 0.0000
376 VISION BLURRED 1 0.0000
377 ARTHRALGIA 3 0.0000
378 DYSPNOEA 4 0.0000
379 PRODUCT DOSE OMISSION ISSUE 2 0.0000
380 VOMITING 3 0.0000
381 HEADACHE 4 0.0000
382 DRUG INTERACTION 1 0.0000
383 PNEUMONIA 2 0.0000
384 URINARY TRACT INFECTION 1 0.0000
385 MYOCARDIAL INFARCTION 1 0.0000
386 COVID-19 1 0.0000
387 NO ADVERSE EVENT 1 0.0000
388 MUSCLE SPASMS 1 0.0000
389 ALOPECIA 1 0.0000
390 HYPERTENSION 1 0.0000
391 MALAISE 2 0.0000
392 WEIGHT INCREASED 1 0.0000
393 COUGH 1 0.0000
394 FALL 1 0.0000
395 DEATH 2 0.0000